Reports from ours and other studies demonstrated that activation of MEK/ERK1/2 or/and AMPK contributed to increase in FOXO3a protein, decrease in cancer cell growth, and other functions in several cell systems [17,43-46]. The gene discussed is MAP2K7; the disease is cancer.